• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p38 调节的 H2AX 磷酸化参与伊马替尼诱导的慢性髓系白血病细胞中 Bim 的表达和凋亡。

H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in chronic myelogenous leukemia cells induced by imatinib.

机构信息

Aviation Medicine Research Laboratory, Air Force General Hospital, PLA, Beijing, 100142, China.

出版信息

Apoptosis. 2014 Aug;19(8):1281-92. doi: 10.1007/s10495-014-0997-9.

DOI:10.1007/s10495-014-0997-9
PMID:24830786
Abstract

Increasing evidence suggests that histone H2AX plays a critical role in regulation of tumor cell apoptosis and acts as a novel human tumor suppressor protein. However, the action of H2AX in chronic myelogenous leukemia (CML) cells is unknown. The detailed mechanism and epigenetic regulation by H2AX remain elusive in cancer cells. Here, we report that H2AX was involved in apoptosis of CML cells. Overexpression of H2AX increased apoptotic sensitivity of CML cells (K562) induced by imatinib. However, overexpression of Ser139-mutated H2AX (blocking phosphorylation) decreased sensitivity of K562 cells to apoptosis. Similarly, knockdown of H2AX made K562 cells resistant to apoptotic induction. These results revealed that the function of H2AX involved in apoptosis is strictly related to its phosphorylation (Ser139). Our data further indicated that imatinib may stimulate mitogen-activated protein kinase (MAPK) family member p38, and H2AX phosphorylation followed a similar time course, suggesting a parallel response. H2AX phosphorylation can be blocked by p38 siRNA or its inhibitor. These data demonstrated that H2AX phosphorylation was regulated by p38 MAPK pathway in K562 cells. However, the p38 MAPK downstream, mitogen- and stress-activated protein kinase-1 and -2, which phosphorylated histone H3, were not required for H2AX phosphorylation during apoptosis. Finally, we provided epigenetic evidence that H2AX phosphorylation regulated apoptosis-related gene Bim expression. Blocking of H2AX phosphorylation inhibited Bim gene expression. Taken together, these data demonstrated that H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in CML cells induced by imatinib.

摘要

越来越多的证据表明组蛋白 H2AX 在肿瘤细胞凋亡的调控中起着关键作用,并作为一种新型的人类肿瘤抑制蛋白发挥作用。然而,H2AX 在慢性粒细胞白血病(CML)细胞中的作用尚不清楚。在癌细胞中,H2AX 的详细作用机制和表观遗传调控仍不清楚。在这里,我们报告 H2AX 参与了 CML 细胞的凋亡。H2AX 的过表达增加了伊马替尼诱导的 CML 细胞(K562)的凋亡敏感性。然而,过表达 Ser139 突变的 H2AX(阻止磷酸化)降低了 K562 细胞对凋亡的敏感性。同样,H2AX 的敲低使 K562 细胞对凋亡诱导产生抗性。这些结果表明,H2AX 参与凋亡的功能与其磷酸化(Ser139)严格相关。我们的数据进一步表明,伊马替尼可能刺激丝裂原活化蛋白激酶(MAPK)家族成员 p38,H2AX 磷酸化也遵循类似的时间过程,表明存在平行反应。H2AX 磷酸化可以被 p38 siRNA 或其抑制剂阻断。这些数据表明 H2AX 磷酸化在 K562 细胞中受到 p38 MAPK 途径的调节。然而,p38 MAPK 的下游分子,丝裂原和应激激活蛋白激酶-1 和 -2,它们磷酸化组蛋白 H3,在凋亡过程中不需要 H2AX 磷酸化。最后,我们提供了表观遗传证据表明 H2AX 磷酸化调节凋亡相关基因 Bim 的表达。阻断 H2AX 磷酸化抑制了 Bim 基因的表达。总之,这些数据表明,由 p38 调节的 H2AX 磷酸化参与了伊马替尼诱导的 CML 细胞中 Bim 表达和凋亡。

相似文献

1
H2AX phosphorylation regulated by p38 is involved in Bim expression and apoptosis in chronic myelogenous leukemia cells induced by imatinib.p38 调节的 H2AX 磷酸化参与伊马替尼诱导的慢性髓系白血病细胞中 Bim 的表达和凋亡。
Apoptosis. 2014 Aug;19(8):1281-92. doi: 10.1007/s10495-014-0997-9.
2
Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation.白藜芦醇通过p38和JNK调节的H2AX磷酸化在体外诱导人慢性粒细胞白血病细胞凋亡。
Acta Pharmacol Sin. 2015 Mar;36(3):353-61. doi: 10.1038/aps.2014.132. Epub 2015 Jan 26.
3
Imatinib induces H2AX phosphorylation and apoptosis in chronic myelogenous leukemia cells in vitro via caspase-3/Mst1 pathway.伊马替尼通过 caspase-3/Mst1 通路诱导慢性髓系白血病细胞中 H2AX 的磷酸化和凋亡。
Acta Pharmacol Sin. 2012 Apr;33(4):551-7. doi: 10.1038/aps.2012.9. Epub 2012 Mar 5.
4
Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia.BIM表达的表观遗传下调与慢性髓性白血病对伊马替尼治疗的最佳反应降低有关。
Eur J Cancer. 2009 Jul;45(10):1877-89. doi: 10.1016/j.ejca.2009.04.005. Epub 2009 May 4.
5
Low-level expression of proapoptotic Bcl-2-interacting mediator in leukemic cells in patients with chronic myeloid leukemia: role of BCR/ABL, characterization of underlying signaling pathways, and reexpression by novel pharmacologic compounds.慢性髓性白血病患者白血病细胞中促凋亡Bcl-2相互作用介质的低水平表达:BCR/ABL的作用、潜在信号通路的特征以及新型药理化合物的重新表达
Cancer Res. 2005 Oct 15;65(20):9436-44. doi: 10.1158/0008-5472.CAN-05-0972.
6
Pml and TAp73 interacting at nuclear body mediate imatinib-induced p53-independent apoptosis of chronic myeloid leukemia cells.Pml与TAp73在核体相互作用介导伊马替尼诱导的慢性髓性白血病细胞非p53依赖的凋亡。
Int J Cancer. 2009 Jul 1;125(1):71-7. doi: 10.1002/ijc.24329.
7
Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.阿克拉霉素 A 通过 p38MAPK 介导的红系分化使 K562 慢性髓系白血病细胞对伊马替尼敏感。
PLoS One. 2013 Apr 17;8(4):e61939. doi: 10.1371/journal.pone.0061939. Print 2013.
8
Imatinib and nilotinib induce apoptosis of chronic myeloid leukemia cells through a Bim-dependant pathway modulated by cytokines.伊马替尼和尼洛替尼通过由细胞因子调节的依赖Bim的途径诱导慢性髓性白血病细胞凋亡。
Cancer Biol Ther. 2007 Jun;6(6):912-9. doi: 10.4161/cbt.6.6.4101. Epub 2007 Mar 5.
9
The roles of epigenetic modifications of proapoptotic BID and BIM genes in imatinib-resistant chronic myeloid leukemia cells.促凋亡基因BID和BIM的表观遗传修饰在伊马替尼耐药慢性髓性白血病细胞中的作用
Hematology. 2013 Jul;18(4):217-23. doi: 10.1179/1607845412Y.0000000056. Epub 2013 Jan 25.
10
Bim and Bad mediate imatinib-induced killing of Bcr/Abl+ leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic.Bim和Bad介导伊马替尼诱导的Bcr/Abl+白血病细胞杀伤,因它们缺失导致的耐药性可被一种BH3模拟物克服。
Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14907-12. doi: 10.1073/pnas.0606176103. Epub 2006 Sep 22.

引用本文的文献

1
Homoharringtonine enhances cytarabine-induced apoptosis in acute myeloid leukaemia by regulating the p38 MAPK/H2AX/Mcl-1 axis.高三尖杉酯碱通过调节p38丝裂原活化蛋白激酶/H2AX/髓细胞白血病-1轴增强阿糖胞苷诱导的急性髓系白血病细胞凋亡。
BMC Cancer. 2024 Apr 24;24(1):520. doi: 10.1186/s12885-024-12286-7.
2
Cancer Drug Resistance: Targeting Proliferation or Programmed Cell Death.癌症耐药性:靶向增殖或程序性细胞死亡
Cells. 2024 Feb 23;13(5):388. doi: 10.3390/cells13050388.
3
Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies.
造血过程中的表观遗传调控及其在血液系统恶性肿瘤靶向治疗中的意义。
Signal Transduct Target Ther. 2023 Feb 17;8(1):71. doi: 10.1038/s41392-023-01342-6.
4
H2A.X Phosphorylation in Oxidative Stress and Risk Assessment in Plasma Medicine.氧化应激与血浆医学风险评估中的 H2A.X 磷酸化
Oxid Med Cell Longev. 2021 Dec 13;2021:2060986. doi: 10.1155/2021/2060986. eCollection 2021.
5
Perturbation of p38α MAPK as a Novel Strategy to Effectively Sensitize Chronic Myeloid Leukemia Cells to Therapeutic BCR-ABL Inhibitors.p38α MAPK 扰动作为一种有效增强慢性髓性白血病细胞对治疗性 BCR-ABL 抑制剂敏感性的新策略。
Int J Mol Sci. 2021 Nov 22;22(22):12573. doi: 10.3390/ijms222212573.
6
PARP-1 overexpression does not protect HaCaT cells from DNA damage induced by SiO nanoparticles.聚(ADP-核糖)聚合酶-1(PARP-1)的过表达并不能保护角质形成细胞(HaCaT细胞)免受二氧化硅纳米颗粒诱导的DNA损伤。
Toxicol Res (Camb). 2021 Apr 12;10(3):399-408. doi: 10.1093/toxres/tfaa110. eCollection 2021 May.
7
Elevated H2AX Phosphorylation Observed with kINPen Plasma Treatment Is Not Caused by ROS-Mediated DNA Damage but Is the Consequence of Apoptosis.KINPen 等离子体处理导致的 H2AX 磷酸化升高不是由 ROS 介导的 DNA 损伤引起的,而是凋亡的后果。
Oxid Med Cell Longev. 2019 Sep 19;2019:8535163. doi: 10.1155/2019/8535163. eCollection 2019.
8
PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis.聚腺苷二磷酸核糖聚合酶抑制剂通过 DNA 损伤和细胞凋亡使阿霉素耐药白血病细胞重新敏感。
Mol Med Rep. 2019 Jan;19(1):75-84. doi: 10.3892/mmr.2018.9628. Epub 2018 Nov 6.
9
A Trib2-p38 axis controls myeloid leukaemia cell cycle and stress response signalling.Trib2-p38 轴控制髓性白血病细胞周期和应激反应信号。
Cell Death Dis. 2018 May 1;9(5):443. doi: 10.1038/s41419-018-0467-3.
10
Astragalin Attenuates UVB Radiation-induced Actinic Keratosis Formation.黄芪苷减轻紫外线辐射诱导的光化性角化病形成。
Anticancer Agents Med Chem. 2018;18(7):1001-1008. doi: 10.2174/1871520618666171229190835.